Cenobamate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Cenobamate
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Cenobamate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

19 API Suppliers, 5 USDMF, 1 EU WC, 6 NDC API, 13 Listed Suppliers, $ API Reference Price

19 API Suppliers
5 USDMF
1 EU WC
6 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

50 Drugs in Development

50 Drugs in Development

FINISHED DOSAGE FORMULATIONS

33 FDF Dossiers, 11 FDA Orange Book, 12 Europe, 10 Canada

33 FDF Dossiers
11 FDA Orange Book
12 Europe
10 Canada

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 42 News #PharmaBuzz

1 Data Compilation #PharmaFlow
42 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 12 Regulatory FDF Prices

1 US Medicaid Prescriptions
12 Regulatory FDF Prices

MARKET PLACE

9 APIs

9 APIs

PATENTS & EXCLUSIVITIES

12 US Patents, 6 US Exclusivities, 16 Health Canada Patents

12 US Patents
6 US Exclusivities
16 Health Canada Patents

$ API Ref.Price (USD/KG) : 2,912 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

16 All

01 16Paladin Pharma Inc.

filter Patent Reset all filters

16 All

01 162606258

filter Product Reset all filters

16 All

01 16CENOBAMATE

filter Dosage Reset all filters

16 All

01 5KIT

02 11TABLET

filter Exp Date Reset all filters

16 All

01 162026-04-21

Metrochem CENOBAMATE

Product Main Page

01

Paladin Pharma Inc.

Cenobamate

CPHI Shenzhen

Not Confirmed

Paladin Pharma Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Brand Name : XCOPRI

Patent Number : 2606258

Filing Date : 2006-04-21

Strength per Unit : 12.5mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Paladin Pharma Inc.

Cenobamate

CPHI Shenzhen

Not Confirmed

Paladin Pharma Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Brand Name : XCOPRI

Patent Number : 2606258

Filing Date : 2006-04-21

Strength per Unit : 25mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Paladin Pharma Inc.

Cenobamate

CPHI Shenzhen

Not Confirmed

Paladin Pharma Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Brand Name : XCOPRI

Patent Number : 2606258

Filing Date : 2006-04-21

Strength per Unit : 50mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Paladin Pharma Inc.

Cenobamate

CPHI Shenzhen

Not Confirmed

Paladin Pharma Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Brand Name : XCOPRI

Patent Number : 2606258

Filing Date : 2006-04-21

Strength per Unit : 100mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Paladin Pharma Inc.

Cenobamate

CPHI Shenzhen

Not Confirmed

Paladin Pharma Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Brand Name : XCOPRI

Patent Number : 2606258

Filing Date : 2006-04-21

Strength per Unit : 150mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Paladin Pharma Inc.

Cenobamate

CPHI Shenzhen

Not Confirmed

Paladin Pharma Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Brand Name : XCOPRI

Patent Number : 2606258

Filing Date : 2006-04-21

Strength per Unit : 200mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Paladin Pharma Inc.

Cenobamate

CPHI Shenzhen

Not Confirmed

Paladin Pharma Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Brand Name : XCOPRI

Patent Number : 2606258

Filing Date : 2006-04-21

Strength per Unit : 12.5 mg / 25 mg

Dosage Form : KIT

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Paladin Pharma Inc.

Cenobamate

CPHI Shenzhen

Not Confirmed

Paladin Pharma Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Brand Name : XCOPRI

Patent Number : 2606258

Filing Date : 2006-04-21

Strength per Unit : 12.5 mg / 25 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

Paladin Pharma Inc.

Cenobamate

CPHI Shenzhen

Not Confirmed

Paladin Pharma Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Brand Name : XCOPRI

Patent Number : 2606258

Filing Date : 2006-04-21

Strength per Unit : 50 mg / 100 mg

Dosage Form : KIT

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

Paladin Pharma Inc.

Cenobamate

CPHI Shenzhen

Not Confirmed

Paladin Pharma Inc.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Brand Name : XCOPRI

Patent Number : 2606258

Filing Date : 2006-04-21

Strength per Unit : 50 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-04-21

Date Granted : 2014-01-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!